Surgical Science Sweden AB (SUS) — Cash Flow Reinvestment Rate
Surgical Science Sweden AB (SUS) has a Cash Flow Reinvestment Rate of 0.27x as of March 2026, reinvesting Skr17.96 Million (capex Skr17.96 Million ) from operating cash flow of Skr65.31 Million. See Surgical Science Sweden AB free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Surgical Science Sweden AB Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Surgical Science Sweden AB across 11 annual periods. For the full cash flow conversion analysis, see how efficiently does Surgical Science Sweden AB generate cash.
Annual Cash Flow Reinvestment Rate for Surgical Science Sweden AB (2015–2025)
Year-by-year capital reinvestment analysis for Surgical Science Sweden AB. See SUS financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.15x | Skr11.68 Million | Skr79.80 Million | Skr11.68 Million | ▼ -78.9% |
| 2024 | 0.69x | Skr95.06 Million | Skr137.22 Million | Skr47.53 Million | ▲ +87.0% |
| 2023 | 0.37x | Skr88.26 Million | Skr238.29 Million | Skr44.13 Million | ▼ -30.6% |
| 2022 | 0.53x | Skr69.10 Million | Skr129.49 Million | Skr34.55 Million | ▼ -99.2% |
| 2021 | 70.29x | Skr2.75 Billion | Skr39.08 Million | Skr14.38 Million | ▲ +9288.1% |
| 2020 | 0.75x | Skr17.39 Million | Skr23.23 Million | Skr8.69 Million | ▼ -81.1% |
| 2019 | 3.97x | Skr219.22 Million | Skr55.20 Million | Skr8.91 Million | ▲ +58.1% |
| 2018 | 2.51x | Skr17.27 Million | Skr6.88 Million | Skr8.64 Million | ▼ -17.7% |
| 2017 | 3.05x | Skr24.23 Million | Skr7.94 Million | Skr12.12 Million | ▲ +249.7% |
| 2016 | 0.87x | Skr11.70 Million | Skr13.40 Million | Skr11.70 Million | ▼ -21.1% |
| 2015 | 1.11x | Skr8.30 Million | Skr7.50 Million | Skr8.30 Million | — |